Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S./EU device MRA implementation by FDA will rely on outside organizations.

This article was originally published in The Gray Sheet

Executive Summary

U.S./EU MRA IMPLEMENTATION BY NON-FDA U.S. ASSESSMENT BODIES PLANNED by the agency, FDA staffers say. Given its resource limitations, FDA is seeking to outsource the European Union CE mark premarket evaluations and facility inspections for conformance to the EU's EN 46000 series quality systems standards mandated by the June device mutual recognition agreement (MRA).

You may also be interested in...



Rep. DeLauro Tries To Block FDA Outsourcing Of Antibiotic Label Updating

FDA's efforts to rely on outside support to carry out its mission have again met with resistance from House Appropriations Subcommittee Chair Rosa DeLauro, D-Conn., who is arguably the agency's most powerful public benefactor

Becton Dickinson, BioMedomics Collaborate On Rapid Serology COVID-19 Test

BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.

UsernamePublicRestriction

Register

MT009328

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel